Moreover, BIRC2 was found to function as an oncogene in NPC, promoting cell proliferation, migration, and invasion as well as xenograft tumor growth and metastasis in vivo, and restoration of BIRC2 expression rescued the inhibitory effect of BRD7 on the malignant phenotype of NPC. This evidence concerns the gene BIRC2 and nasopharyngeal carcinoma.